These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28733768)

  • 1. Estimates of health utility scores in chronic kidney disease.
    Sekercioglu N; Curtis B; Murphy S; Blackhouse G; Barrett B
    Int Urol Nephrol; 2017 Nov; 49(11):2043-2049. PubMed ID: 28733768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life and estimates of utility in chronic kidney disease.
    Gorodetskaya I; Zenios S; McCulloch CE; Bostrom A; Hsu CY; Bindman AB; Go AS; Chertow GM
    Kidney Int; 2005 Dec; 68(6):2801-8. PubMed ID: 16316356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation.
    Jo MW; Lee HJ; Ryu DR; Park J; Ock M; Kim SH
    Nephrology (Carlton); 2020 Jul; 25(7):544-550. PubMed ID: 32026549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.
    Verberne WR; Dijkers J; Kelder JC; Geers ABM; Jellema WT; Vincent HH; van Delden JJM; Bos WJW
    BMC Nephrol; 2018 Aug; 19(1):205. PubMed ID: 30115028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments.
    Wyld M; Morton RL; Hayen A; Howard K; Webster AC
    PLoS Med; 2012; 9(9):e1001307. PubMed ID: 22984353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.
    Wu HY; Fukuma S; Shimizu S; Norton EC; Tu YK; Hung KY; Chen MR; Chien KL; Fukuhara S
    Am J Kidney Dis; 2017 Nov; 70(5):666-674. PubMed ID: 28764919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.
    Cooper JT; Lloyd A; Sanchez JJG; Sörstadius E; Briggs A; McFarlane P
    Health Qual Life Outcomes; 2020 Sep; 18(1):310. PubMed ID: 32957990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life of young adults and adolescents with chronic kidney disease.
    Tong A; Wong G; McTaggart S; Henning P; Mackie F; Carroll RP; Howard K; Craig JC
    J Pediatr; 2013 Oct; 163(4):1179-85.e5. PubMed ID: 23800404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England.
    Nguyen NTQ; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
    PLoS One; 2018; 13(11):e0207960. PubMed ID: 30475893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease.
    Zimbudzi E; Lo C; Ranasinha S; Gallagher M; Fulcher G; Kerr PG; Russell G; Teede H; Usherwood T; Walker R; Zoungas S
    PLoS One; 2016; 11(12):e0168491. PubMed ID: 27992595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.
    Habbous S; Przech S; Martin J; Garg AX; Sarma S
    Value Health; 2018 Mar; 21(3):318-325. PubMed ID: 29566839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in kidney transplant patients and non-renal replacement therapy patients with chronic kidney disease stages 3b-4.
    Stømer U; Bergrem H; Gøransson LG
    Ann Transplant; 2013 Nov; 18():635-42. PubMed ID: 24241237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients.
    Nguyen HV; Bose S; Finkelstein E
    BMC Nephrol; 2016 Apr; 17(1):45. PubMed ID: 27121505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2013; 16(6):1032-45. PubMed ID: 24041353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.
    Kharroubi SA
    Value Health Reg Issues; 2022; 27():1-11. PubMed ID: 34784542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.
    Moreira JM; Bouissou Morais Soares CM; Teixeira AL; Simões E Silva AC; Kummer AM
    Pediatr Nephrol; 2015 Dec; 30(12):2153-62. PubMed ID: 26210984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; Yang Y
    Value Health; 2014 Jun; 17(4):406-15. PubMed ID: 24969001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.